Drug Reconstitution at the Point-of-Care: Therapeutic Markets, Technologies, Strategies, and Prospects
- Language: English
- Published: January 2012
The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.
- Analyzes therapeutic demand drivers and evaluates specialty injectables in ten major therapeutic markets
- Analyzes design factors, material selection issues, technologies and market development issues
- Assess significant managed care, technology, and regulatory factors affecting specialty injectable drug markets.
- Provides market data and forecasts to 2020
1. Executive Summary
4. Autoimmune Diseases
5. Multiple Sclerosis
8. Hormone Replacement
11. Reproductive Health